Half-year report · Q2
3154.TEDINET S100V7O6
Period2024-07-01 → 2024-12-31
Filed2025-02-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥142.7bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥259.8bn | 2023-07-01 → 2024-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥126.7bn | 2023-07-01 → 2023-12-31 | Cons. | Net sales |
| Operating income | ¥751m | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Operating income | ¥681m | 2023-07-01 → 2023-12-31 | Cons. | Operating income |
| Ordinary income | ¥983m | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.8bn | 2023-07-01 → 2024-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥900m | 2023-07-01 → 2023-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥983m | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥895m | 2023-07-01 → 2023-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥407m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.1bn | 2023-07-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥505m | 2023-07-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥407m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Net income | ¥505m | 2023-07-01 → 2023-12-31 | Cons. | Profit loss |
| Total assets | ¥119.8bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥114.8bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥112.6bn | at 2023-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥99.8bn | at 2024-12-31 | Cons. | Liabilities |
| Total liabilities | ¥95.1bn | at 2024-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥20.0bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥19.7bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥18.6bn | at 2023-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥14.0bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥13.6bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥14.0bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.5bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.0bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.3bn | at 2023-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.5bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.9bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.5bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.4bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.7bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.5bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥586m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥4.0bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6.7bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥18.32 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥51.21 | 2023-07-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.03 | 2023-07-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥18.32 | 2024-07-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥51 | 2023-07-01 → 2024-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥22.93 | 2023-07-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 16.7% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.2% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 16.5% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥9m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥9m |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥4.5bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥139.7bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥139.7bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥9m |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥5.0bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥3.0bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥3.0bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥250m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2024-12-31 | ¥142.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2024-12-31 | ¥142.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥9m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2024-12-31 | ¥5.3bn |
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2023-12-31 | −¥7m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2023-12-31 | −¥7m |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2023-12-31 | −¥4.2bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥123.8bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥123.8bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥7m |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥4.6bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥2.9bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥2.9bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥201m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-07-01 → 2023-12-31 | ¥126.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-07-01 → 2023-12-31 | ¥126.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥7m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-07-01 → 2023-12-31 | ¥4.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 558
| Item | Context | Value | Unit |
|---|---|---|---|
| Long term loans payable | Prior1YearInstant | 4196120000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 4632709000 | JPY |
| Provision for directors retirement benefits | Prior1YearInstant | 159000000 | JPY |
| Provision for directors retirement benefits | CurrentQuarterInstant | 157000000 | JPY |
| Provision for share based payments ncl | Prior1YearInstant | - | JPY |
| Provision for share based payments ncl | CurrentQuarterInstant | 11009000 | JPY |
| Provision for loss on guarantees | Prior1YearInstant | 113596000 | JPY |
| Provision for loss on guarantees | CurrentQuarterInstant | 113325000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 1422014000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 1509624000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 161320000 | JPY |
| Asset retirement obligations ncl | CurrentQuarterInstant | 162134000 | JPY |
| Long term unearned revenue | Prior1YearInstant | 3292241000 | JPY |
| Long term unearned revenue | CurrentQuarterInstant | 3203136000 | JPY |
| Other ncl | Prior1YearInstant | 1410442000 | JPY |
| Other ncl | CurrentQuarterInstant | 1706076000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 10762736000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 11499516000 | JPY |
| Liabilities | Prior1YearInstant | 95089368000 | JPY |
| Liabilities | CurrentQuarterInstant | 99820131000 | JPY |
| Capital stock | Prior1YearInstant | 1344769000 | JPY |
| Capital stock | CurrentQuarterInstant | 1380877000 | JPY |
| Capital surplus | Prior1YearInstant | 2843805000 | JPY |
| Capital surplus | CurrentQuarterInstant | 2879912000 | JPY |
| Retained earnings | Prior1YearInstant | 13334463000 | JPY |
| Retained earnings | CurrentQuarterInstant | 13237369000 | JPY |
| Treasury stock | Prior1YearInstant | -450000 | JPY |
| Treasury stock | CurrentQuarterInstant | -450000 | JPY |
| Shareholders equity | Prior1YearInstant | 17522588000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 17497710000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 2136083000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 2406895000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 78753000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 79996000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 2214837000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 2486891000 | JPY |
| Net assets | Prior1YearInstant | 19737425000 | JPY |
| Net assets | CurrentQuarterInstant | 19984601000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 114826794000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 119804733000 | JPY |
| Net sales | Prior1YTDDuration | 126713055000 | JPY |
| Net sales | CurrentYTDDuration | 142704820000 | JPY |
| Cost of sales | Prior1YTDDuration | 111574272000 | JPY |
| Cost of sales | CurrentYTDDuration | 125826257000 | JPY |
| Gross profit | Prior1YTDDuration | 15138782000 | JPY |
| Gross profit | CurrentYTDDuration | 16878562000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | -641000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | 9003000 | JPY |
| Provision for share based payments sga | Prior1YTDDuration | 9643000 | JPY |
| Provision for share based payments sga | CurrentYTDDuration | 1510000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |